cancer antigenic peptide database cancer antigen - CancerantigensDatabase peptide Unveiling the Cancer Antigenic Peptide Database: A Cornerstone in Cancer Research and Therapy

CancerantigensDatabase The quest to conquer cancer is an ongoing, multi-faceted scientific endeavor. Central to many of these efforts, particularly in the realm of immunotherapy, is a deep understanding of cancer antigens and their corresponding peptides. This knowledge is meticulously curated and made accessible through specialized resources like the cancer antigenic peptide database. These databases serve as invaluable repositories, housing experimental data on antibody and T cell peptidic epitopes and playing a crucial role in advancing our comprehension of cancer biology and the development of novel therapeutic strategies作者：S Lemke·2025·被引用次数：5—The Peptides for Cancer Immunotherapy Database (PCI-DB)includes over 6.6 million HLA class I and over 3.4 million HLA class II peptidesfrom ....

The concept of a cancer peptide database has roots stretching back to at least 2001, when efforts began to systematically compile relevant human tumor antigens and their associated peptides.Search Over the years, these compilations have evolved into sophisticated platforms, essential for researchers worldwide. The primary objective of these databases is to provide a comprehensive collection of cancer epitope and receptor data, enabling scientists to explore this complex landscape efficiently.

Several key databases have emerged as prominent resources in this field.Cancer Peptide Database. Many tumor cells produce peptide antigens. These may be released in the bloodstream or remain on the cell surface. The Cancer Antigenic Peptide Database (CAPDb), for instance, is a well-established resource that contains experimentally validated tumor antigensMARS: Improved De Novo Peptide Candidate Selection for .... It has been instrumental in compiling data from recent publications, contributing to resources like TANTIGEN versions. While early versions of the Cancer Antigenic Peptide Database contained a limited number of entries for cancer neoepitopes, the scope and depth of such databases have significantly expandedTANTIGEN - Database Commons. Another significant contribution comes from the Cancer Epitope Database and Analysis Resource (CEDAR), which provides a freely accessible treasure trove of curated data. CEDAR catalogsexperimental data on antibody and T cell peptidic epitopes primarily studied in humans and non-human primates in the context of cancer disease, offering crucial insights for cancer immunotherapy research作者：S Sotirov·2024·被引用次数：18—TheCancer Antigenic Peptide Database(CAPDb, https://caped.icp.ucl.ac.be/) [96] is a comprehensive database of experimentally validated tumor antigens ....

Beyond these overarching databases, specialized platforms cater to specific aspects of cancer antigen research. For example, caAtlas functions as a comprehensive resource for selecting and prioritizing peptides for immunogenicity testing and cancer immunotherapy development. It is described as an immunopeptidome atlas of human cancer, built upon an extensive collection of published immunopeptidomic datasets and standardized analyses. Similarly, TumorAgDB1.0 is a powerful tool designed for neoantigen screening and validation in tumor immunotherapy, offering strong support to researchers by providing a tumor neoantigen database platform.

The importance of these databases is underscored by the ongoing advancements in cancer treatment modalities. Immunotherapy, in particular, relies heavily on the precise identification of antigensTANTIGEN 2.0: a knowledge base of tumor T cell antigens .... Peptide antigens, whether they are released into the bloodstream or remain on the cell surface of tumor cells, are key targets for the immune system.ASH Annual Meeting & Exposition The accurate identification and prioritization of antigenic peptides are crucial for the development of personalized cancer immunotherapies.Description:Tumor T cell antigen databaseis a data source and analysis platform for cancer vaccine target discovery focusing on human tumor antigens that ... Databases like the Cancer Antigenic Peptide Database are therefore vital for discovering novel therapeutic targets and developing effective cancer vaccines.Antigen- Peptide Database· CRISPR gRNA database · GenScript Referral Program · Testimonials Submission · Customer Testimonials · GenSpark Points Program.

The types of antigens cataloged within these databases are diverse. They can encompass cancer self-antigen and nonself-antigens, including tumor antigens that are classified into different categoriesCAD v1.0: Cancer Antigens Database Platform for Cancer .... Researchers can find information on cancer-testis antigens, which are expressed in tumor cells and germ cells, making them attractive targets for immunotherapy. Furthermore, some databases may include insights into noncoding cryptic peptides, which have emerged as an important class of immunogenic antigens in certain cancers.

The data contained within these resources is not static. Continuous updates and compilations ensure that they remain at the forefront of research.2025年12月17日—KEGG PATHWAY is a collection of manually drawn pathway maps representing our knowledge of the molecular interaction, reaction and relation networks. For instance, some platforms integrate data from existing valuable databases, reflecting the collaborative nature of scientific advancement.2025年2月19日—This study revealsnoncoding cryptic peptidesas an important class of immunogenic antigens in OC. The development of platforms like the Cancer Antigens Database (CAD) further enhances the ability of users to perform comprehensive explorations of cancer antigens online.

The broad spectrum of information available through these databases is essential for various research purposes. They facilitate the interpretation of publications related to cancer clinical research, such as the BRCALit database, which focuses on breast cancer. They also support the identification of potential cancer therapeutic targets, contributing to the development of new drugs and treatment protocols. The Peptides for Cancer Immunotherapy Database (PCI-DB), for example, includes millions of HLA class I and class II peptides, providing extensive data for immunotherapy design.

In essence, the cancer antigenic peptide database is more than just a collection of data; it is a foundational element in the fight against cancer.作者：F Huber·2024·被引用次数：66—The accurate identification and prioritization ofantigenicpeptides is crucial for the development of personalizedcancerimmunotherapies. By providing researchers with readily accessible, detailed, and experimentally validated information on antigens, peptides, and epitopes, these databases fuel innovation, accelerate discovery, and ultimately pave the way for more effective and targeted cancer therapiesCancer peptide database for tumor-associated antigens. The continuous evolution and expansion of these resources are a testament to their critical role in advancing our understanding and treatment of this complex disease.